Analysis of ultrasonically extracted interstitial fluid as a predictor of blood glucose levels.

Transdermal extraction of clinically relevant analytes offers a potentially noninvasive method of diagnostics. However, development of such a method is limited by the low permeability of skin. In this paper, we present a potential method for noninvasive diagnostics based on ultrasonic skin permeabilization and subsequent extraction of interstitial fluid (ISF) across the skin using vacuum. ISF extracted by this method was collected and analyzed for glucose and other analytes. Glucose concentration in the extracted fluid correlates well with blood glucose concentration over a range of 50-250 mg/dl. A mathematical model describing vacuum-induced transport of ISF through ultrasonically permeabilized skin is presented as well. The model accounts for convective, as well as diffusive, transport processes across blood capillaries, epidermis, and the stratum corneum. The overall predictions of the model compare favorably with the experimental observations.

[1]  S. Mitragotri,et al.  A mechanistic study of ultrasonically-enhanced transdermal drug delivery. , 1995, Journal of pharmaceutical sciences.

[2]  D. Cox,et al.  Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose , 1987, Diabetes Care.

[3]  O. Takatani,et al.  A novel blood glucose monitoring system based on an ISFET biosensor and its application to a human 75 g oral glucose tolerance test , 1990 .

[4]  Russell O. Potts,et al.  Measurement of glucose in diabetic subjects using noninvasive transdermal extraction , 1995, Nature Medicine.

[5]  J N Roe,et al.  Bloodless glucose measurements. , 1998, Critical reviews in therapeutic drug carrier systems.

[6]  J. Weaver,et al.  Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Samir Mitragotri,et al.  Transdermal monitoring of glucose and other analytes using ultrasound , 2000, Nature Medicine.

[8]  D C Klonoff.  Noninvasive blood glucose monitoring. , 1997, Diabetes care.

[9]  A. Jarrett.  The physiology and pathophysiology of the skin. , 1973, Lancet.

[10]  S. Mitragotri,et al.  Ultrasound-mediated transdermal protein delivery , 1995, Science.

[11]  R. Stoughton.  Percutaneous absorption: Mechanisms—methodology-drug delivery, Bronaugh Robert L., Howard I. Maibach (Eds.). Marcel Dekker Inc., New York (1989), 632, $125.00 , 1990 .

[12]  T Terahara,et al.  Determination of threshold energy dose for ultrasound-induced transdermal drug transport. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[13]  J L Bert,et al.  Microvascular exchange and interstitial volume regulation in the rat: implications of the model. , 1989, The American journal of physiology.

[14]  Tsunenori Arai,et al.  A Novel Blood Glucose Monitoring Method an ISFET Biosensor Applied to Transcutaneous Effusion Fluid , 1989 .

[15]  T. Franz.  Percutaneous Absorption: Mechanisms—Methodology—Drug Delivery , 1990 .

[16]  H M Heise.  Non-invasive monitoring of metabolites using near infrared spectroscopy: state of the art. , 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.